心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2019 HFA/ESC共识建议：射血分数保留的心衰的诊断- HFA-PEFF诊断流程

2019-08-31 欧洲心力衰竭协会 Eur Heart J. 2019 Aug 31.

保留射血分数心衰诊断

使用保留射血分数（HFpEF）确诊慢性心力衰竭仍具有调整，本文推荐一个新的逐步诊断的过程，新的心衰诊断建议共分为4个步骤，检测前评估，超声心动图和利钠肽评分，功能性检测，最终病因学检查。

中文标题：

2019 HFA/ESC共识建议：射血分数保留的心衰的诊断- HFA-PEFF诊断流程

英文标题：

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

发布机构：

欧洲心力衰竭协会

发布日期：

2019-08-31

简要介绍：

使用保留射血分数（HFpEF）确诊慢性心力衰竭仍具有调整，本文推荐一个新的逐步诊断的过程，新的心衰诊断建议共分为4个步骤，检测前评估，超声心动图和利钠肽评分，功能性检测，最终病因学检查。

 

拓展指南：与心衰相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 HFA/ESC共识建议：射血分数保留的心衰的诊断- HFA-PEFF诊断流程)] GetToolGuiderByIdResponse(projectId=1, id=7a6591c001e913c3, title=2019 HFA/ESC共识建议：射血分数保留的心衰的诊断- HFA-PEFF诊断流程, enTitle=How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)., guiderFrom=Eur Heart J. 2019 Aug 31., authorId=null, author=, summary=使用保留射血分数（HFpEF）确诊慢性心力衰竭仍具有调整，本文推荐一个新的逐步诊断的过程，新的心衰诊断建议共分为4个步骤，检测前评估，超声心动图和利钠肽评分，功能性检测，最终病因学检查。 , cover=, journalId=null, articlesId=null, associationId=395, associationName=欧洲心力衰竭协会, associationIntro=欧洲心力衰竭协会(HFA,Heart Failure Association)是注册于欧洲心脏病学会ESC的分支机构，于2004年8月在慕尼黑正式启动，由已解散的前ESC工作心衰组创建。拥有约3800会员，致力于心衰的教育和研究。, copyright=0, guiderPublishedTime=Sat Aug 31 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>使用保留射血分数（HFpEF）确诊慢性心力衰竭仍具有调整，本文推荐一个新的逐步诊断的过程，新的心衰诊断建议共分为4个步骤，检测前评估，超声心动图和利钠肽评分，功能性检测，最终病因学检查。 </P> <P> </P>拓展指南：<strong>与<font color=red>心衰</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=243121c001e79708" title="2019 EAPC立场声明：心衰患者的姑息治疗" target=_blank>2019 EAPC立场声明：心衰患者的姑息治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f73ad1c001ea7912" title="2019 AHA/HFSA科学声明：2型糖尿病和心衰" target=_blank>2019 AHA/HFSA科学声明：2型糖尿病和心衰</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a58fb1c001e20217" title="2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质" target=_blank>2019 HFSA共识声明：心衰患者的营养，肥胖和恶病质</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=bb4f91c001692159" title="2019 KSHF指南：急性心衰的管理：第3部分—基于病因和并发症的具体处理" target=_blank>2019 KSHF指南：急性心衰的管理：第3部分—基于病因和并发症的具体处理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=25ce91c001692086" title="2019 KSHF指南：急性心衰的管理：第2部分—急性心衰的治疗" target=_blank>2019 KSHF指南：急性心衰的管理：第2部分—急性心衰的治疗</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%A1%B0" target=_blank>有关心衰更多指南</a></ul>, tagList=[TagDto(tagId=56259, tagName=保留射血分数), TagDto(tagId=94550, tagName=心衰诊断)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18424, appHits=705, showAppHits=0, pcHits=14316, showPcHits=5569, likes=92, shares=29, comments=5, approvalStatus=1, publishedTime=Mon Sep 16 22:50:00 CST 2019, publishedTimeString=2019-08-31, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Sep 16 22:50:00 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:00:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 HFA/ESC共识建议：射血分数保留的心衰的诊断- HFA-PEFF诊断流程)])
2019 HFA/ESC共识建议：射血分数保留的心衰的诊断- HFA-PEFF诊断流程
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1247496, encodeId=caf2124e49622, content=研究一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9668303888, createdName=ms1000000565415296, createdTime=Tue Sep 06 15:47:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966379, encodeId=61789663e9b9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/48deedac880146c9bafbcbbd89dd4040/aa29c35dd33d408d9546ff70befc9cc8.jpg, createdBy=256c5501937, createdName=ms7000000065929849, createdTime=Mon May 17 20:17:31 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963956, encodeId=697d96395696, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acf05457575, createdName=ms4000001119337511, createdTime=Sun May 09 13:18:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907986, encodeId=8ad790e986c3, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyR0jWA7H3MiaB45okXhicCvKW10rMjobB9HyJIxxBgguuqPg8QUiaIKlBGCiatRENTYG2aNwAu8VCZw/132, createdBy=05d25137109, createdName=ms412091436248357, createdTime=Mon Dec 14 22:29:08 CST 2020, time=2020-12-14, status=1, ipAttribution=)]
    2022-09-06 ms1000000565415296

    研究一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1247496, encodeId=caf2124e49622, content=研究一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9668303888, createdName=ms1000000565415296, createdTime=Tue Sep 06 15:47:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966379, encodeId=61789663e9b9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/48deedac880146c9bafbcbbd89dd4040/aa29c35dd33d408d9546ff70befc9cc8.jpg, createdBy=256c5501937, createdName=ms7000000065929849, createdTime=Mon May 17 20:17:31 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963956, encodeId=697d96395696, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acf05457575, createdName=ms4000001119337511, createdTime=Sun May 09 13:18:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907986, encodeId=8ad790e986c3, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyR0jWA7H3MiaB45okXhicCvKW10rMjobB9HyJIxxBgguuqPg8QUiaIKlBGCiatRENTYG2aNwAu8VCZw/132, createdBy=05d25137109, createdName=ms412091436248357, createdTime=Mon Dec 14 22:29:08 CST 2020, time=2020-12-14, status=1, ipAttribution=)]
    2021-05-17 ms7000000065929849

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1247496, encodeId=caf2124e49622, content=研究一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9668303888, createdName=ms1000000565415296, createdTime=Tue Sep 06 15:47:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966379, encodeId=61789663e9b9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/48deedac880146c9bafbcbbd89dd4040/aa29c35dd33d408d9546ff70befc9cc8.jpg, createdBy=256c5501937, createdName=ms7000000065929849, createdTime=Mon May 17 20:17:31 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963956, encodeId=697d96395696, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acf05457575, createdName=ms4000001119337511, createdTime=Sun May 09 13:18:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907986, encodeId=8ad790e986c3, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyR0jWA7H3MiaB45okXhicCvKW10rMjobB9HyJIxxBgguuqPg8QUiaIKlBGCiatRENTYG2aNwAu8VCZw/132, createdBy=05d25137109, createdName=ms412091436248357, createdTime=Mon Dec 14 22:29:08 CST 2020, time=2020-12-14, status=1, ipAttribution=)]
    2021-05-09 ms4000001119337511

    学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1247496, encodeId=caf2124e49622, content=研究一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9668303888, createdName=ms1000000565415296, createdTime=Tue Sep 06 15:47:42 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966379, encodeId=61789663e9b9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/48deedac880146c9bafbcbbd89dd4040/aa29c35dd33d408d9546ff70befc9cc8.jpg, createdBy=256c5501937, createdName=ms7000000065929849, createdTime=Mon May 17 20:17:31 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963956, encodeId=697d96395696, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acf05457575, createdName=ms4000001119337511, createdTime=Sun May 09 13:18:37 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907986, encodeId=8ad790e986c3, content=👍🏻, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKyR0jWA7H3MiaB45okXhicCvKW10rMjobB9HyJIxxBgguuqPg8QUiaIKlBGCiatRENTYG2aNwAu8VCZw/132, createdBy=05d25137109, createdName=ms412091436248357, createdTime=Mon Dec 14 22:29:08 CST 2020, time=2020-12-14, status=1, ipAttribution=)]
    2020-12-14 ms412091436248357

    👍🏻

    0